期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Rescue with intravitreal bevacizumab in aggressive posterior retinopathy of prematurity poorly responsive to laser treatment
1
作者 Vivek Kumar Ravish Kinkhabwala +3 位作者 Parijat Chandra Brijesh Takkar Shorya Vardhan Azad Rajvardhan Azad 《Annals of Eye Science》 2018年第1期69-72,共4页
Successful management of a case of aggressive posterior retinopathy of prematurity(APROP)poorly responsive to laser therapy with intravitreal bevacizumab(IVB)is discussed.IVB is useful as rescue therapy in such cases,... Successful management of a case of aggressive posterior retinopathy of prematurity(APROP)poorly responsive to laser therapy with intravitreal bevacizumab(IVB)is discussed.IVB is useful as rescue therapy in such cases,if given within the correct window period post laser therapy. 展开更多
关键词 aggressive posterior retinopathy of prematurity(APROP) anti-vascular endothelial growth factor(anti-VEGF) laser in retinopathy of prematurity(ROP)
下载PDF
ntravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity 被引量:2
2
作者 Xiu-Juan Li Xiao-Peng Yang +2 位作者 Shuang Sun Xiao-Bei Lyu Heng Jia 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第23期2879-2881,共3页
Retinopathy ofprematurity (ROP) is a proliferative disease that affects infants of young gestational age (GA) and low birth weight (BW). Aggressive posterior ROP (AP-ROP) is a rapidly progressing and severe pr... Retinopathy ofprematurity (ROP) is a proliferative disease that affects infants of young gestational age (GA) and low birth weight (BW). Aggressive posterior ROP (AP-ROP) is a rapidly progressing and severe presentation of ROP. It is characterized as posterior location (zone 1 or posterior zone I1), Stage 3, and with plus disease (arterial tortuosity and venous dilation). It can quickly lead to retinal detachment and blindness if not treated in time. 展开更多
关键词 aggressive posterior retinopathy of prematurity Intravitreal Injection RANIBIZUMAB
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部